Chapter 57: Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/45

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

46 Terms

1
New cards

What are the major characterizations of attention deficit hyperactivity disorder (ADHD)?

  • Persistent hyperactivity

  • Short attention span

  • Difficulty completing assigned tasks

  • Restlessness

  • Impulsiveness

2
New cards

What is the most common psychiatric/neurobehavioral disorder in children?

ADHD

3
New cards

Describe the etiology of ADHD

ADHD may be an inherited disorder and with subtle dysfunction in the frontal lobe and functionally related subcritical structures playing a major role in clinical manifestations. Dopamine and norepinephrine transport dysfunction in the brain has also been implicated.

4
New cards

At what ages is ADHD usually diagnosed?

3-7 years old

5
New cards

Describe how children with ADHD may act in social settings

Children with ADHD may find it harder to get along with others and may find difficulty in situations requiring controlled behavior.

6
New cards

Which gender is more susceptible to ADHD?

Males

7
New cards

In addition to ADHD, what other disorders may children with ADHD may also have that hinders academic and emotional development?

Learning Disabilties

8
New cards

Describe ADHD in adolescents and adults

~50% of children diagnosed with ADHD will still have ADHD by the time they are adolescents and/or adults. In adolescents/adults with ADHD, hyperactivity is usually not apparent, however, impulsiveness, inattention, and difficulties in structured environments are usually prominent. Diagnosis of ADHD in adults has increased in recent years.

9
New cards

Indications for usage of drug therapy in those with ADHD

  • Moderate to severe symptoms

  • Symptoms persist for several months

  • Symptoms interfere with special, academic, and/or behavioral functioning

10
New cards

What are the goals of treatment of ADHD?

  • Symptom control (Based on individual S/S)

  • Facilitation of learning

  • Promotion of social development

11
New cards

In addition to drug therapy, what else should treatment of ADHD include?

Counseling and Psychotherapy

12
New cards

How should activity timing with relation to pediatric ADHD be approached?

Many children with ADHD will greatly benefit from short, intense periods of physical activity.

13
New cards

What are the major characteristics of Narcolepsy?

  • Excessive sleepiness

  • Sleep attacks at inappropriate times

14
New cards

Clinical Manifestations of Narcolepsy

  • Disturbed nocturnal sleep

  • Abnormal daytime sleep pattern

  • Cataplexy

  • Hypnagogic hallucinations

  • Sleep paralysis

15
New cards

What factors are involved in the development of narcolepsy?

  • Genetics (Genetic variation and congenital)

  • Environmental (Infections)

16
New cards

Hypnagogic Hallucinations are a clinical manifestation of narcolepsy. What are they?

Vivid, many times frightening, dreamlike experiences that occurs while dozing, falling, asleep, or awakening.

17
New cards

Describe Cataplexy

Episodic, sudden loss of muscle tone in response to strong emotion.

18
New cards

What are the two major forms of narcolepsy?

  • Type 1

  • Type 2

19
New cards

Describe Type 1 Narcolepsy

Narcolepsy with cataplexy. This type is associated with significant loss of neurons and orexin neuropeptides.

20
New cards

Describe Orexin Neuropeptides

Orexin-A (Hypcretin-1) and Orexin-B (Hypocretin-2) are neuropeptides made by the hypothalamus. They have excitatory effects when released during wakefulness and increases other brain activity involved in wakefulness.

21
New cards

Loss of orexin signaling has been implicated as a cause of Type 1 Narcolepsy. Why?

Loss of excitatory Orexin-A and Orexin-B enables for REM sleep-related phenomena to intrude into wakefulness. This is caused by death of orexin-producing neurons. The cause of this neuronal death is unknown but may be autoimmune in nature.

22
New cards

What is HLA-DBQ1?

A gene belonging to a family of genes called the human leukocyte antigen (HLA) complex. This gene is involved producing a protein that plays a role in how the immune system reacts to foreign proteins. A variation of this gene had been linked to those with Type 1 narcolepsy.

23
New cards

Describe Type 2 Narcolepsy

Narcolepsy without cataplexy. This type of narcolepsy has an unknown etiology.

24
New cards

Other than medications, what else can a patient with narcolepsy benefit from?

  • Avoidance of shift work

  • Short naps

25
New cards

Goal of Narcolepsy Treatment

  • Prevention of sleep deprivation

  • Regular sleep and waking times

*Treatment based on individual S/S

26
New cards

What drug classes are given for the treatment of ADHD and Narcolepsy?

  1. Amphetamines

  2. Amphetamine-Related CNS Stimulants

  3. Selective Norepinephrine Reuptake Inhibitors

  4. Sympatholytics

  5. CNS Depressants

  6. Xanthines

27
New cards

Amphetamine Prototype

Dextroamphetamine (Dexedrine)

*These medication are Schedule II Drugs

28
New cards

Dextroamphetamine (Dexedrine) Action

Triggers increase of norepinephrine, dopamine (Higher doses), and possibly serotonin in the brain.

29
New cards

Describe how stimulants in general aid those with ADHD and/or Narcolepsy

Facilitation of the initiation and transmission of nerve impulses that excites other cells.

30
New cards

How can Stimulants benefit a patient with ADHD?

Improvement in academic performance, behavior, and interpersonal relationships.

31
New cards

How can Stimulants benefit a patient with narcolepsy?

Improvement in the performance of daily activities.

32
New cards

Amphetamine-Related CNS Stimulants Prototype

Methylphenidate (Ritalin)

*These medications are Schedule II Drugs and are widely sold on the street

33
New cards

Methylphenidate (Ritalin) Action

Mild cortical stimulant and acts on CNS-like amphetamines.

34
New cards

Describe Modafinil

An Amphetamine-Related CNS Stimulant used to help with the fatigue associated with ADHD activity.

35
New cards

Selective Norepinephrine Reuptake Inhibitor Prototype

Atomoxetine (Strattera)

36
New cards

Atomoxetine (Strattera) Action

Inhibits reuptake of norepinephrine in nerve synapses

37
New cards

Sympatholytic Prototype

Guanfacine (Intuniv)

38
New cards

Guanfacine (Intuniv) Action

Selective agonist of postsynaptic Alpha2A-Adrenoreceptors in the prefrontal cortex. The result is believed to be improvement in delay-related firing of prefrontal cortex neurons affecting working memory and behavioral inhibition. Decreased sympathetic nerve impulse leading to reduced sympathetic outflow and decreased vasomotor tone and HR is also triggered.

39
New cards

Guanfacine (Intuniv) Uses

  • Used when atomoxetine is ineffective or triggers adverse side effects

40
New cards

CNS Depressant Prototype

Sodium Oxybate (Xyrem)

41
New cards

Sodium Oxybate (Xyrem) Action

Depression of the CNS.

42
New cards

Xanthine Prototype

Caffeine

43
New cards

What is the most commonly consumed CNS stimulant in the world?

Caffeine (Usually from dietary sources)

44
New cards

Caffeine effects in low to moderate amounts

  • Increased alertness

  • Wakefulness

  • Increased capacity to work

45
New cards

Caffeine effects in large amounts

  • CNS

    • Anxiety

    • Agitation/Irritability

    • Hyperactivity

    • Insomnia

    • Nervousness

    • Restlessness

  • G.I.

    • Diarrhea

    • Nausea

    • Vomiting

  • CV

    • PVC

    • Tachycardia

  • Musculoskeletal

    • Tremors

46
New cards

Caffeine effects in toxic amounts

Delirium and Seizures